SCHEMBL20617569

SCHEMBL20617569

O=C1O[C@H]2CCCCCC[C@H]12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 9/20 0.36
F2 P00734 8/20 0.36
CTRC Q99895 2/20 0.36
DAO P14920 2/20 0.33
KDM4E B2RXH2 1/20 0.31
GMNN O75496 1/20 0.31
PPM1B O75688 1/20 0.31
LMNA P02545 1/20 0.31
PPP1CC P36873 1/20 0.31
TFPI2 P48307 1/20 0.31
RAB9A P51151 1/20 0.31
PPP5C P53041 1/20 0.31
PPP1CA P62136 1/20 0.31
PMP22 Q01453 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
TP53 P04637 1/20 0.31
CYP2D6 P10635 1/20 0.31
NFKB1 P19838 1/20 0.31
THPO P40225 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4046094 1.00 PRSS1 (0.36) PRSS1F2CTRCDAOKDM4E
SCHEMBL11805630 1.00 PRSS1 (0.36) PRSS1F2CTRCDAOKDM4E
SCHEMBL52434 1.00 PRSS1 (0.36) PRSS1F2CTRCDAOKDM4E
SCHEMBL2962078 1.00 PRSS1 (0.36) PRSS1F2CTRCDAOKDM4E
SCHEMBL2954265 1.00 PRSS1 (0.36) PRSS1F2CTRCDAOKDM4E
SCHEMBL11803699 1.00 PRSS1 (0.36) PRSS1F2CTRCDAOKDM4E
SCHEMBL19212607 1.00 PRSS1 (0.36) PRSS1F2CTRCDAOKDM4E
SCHEMBL4046976 1.00 PRSS1 (0.36) PRSS1F2CTRCDAOKDM4E
SCHEMBL20618128 1.00 PRSS1 (0.36) PRSS1F2CTRCDAOKDM4E
SCHEMBL52348 1.00 PRSS1 (0.36) PRSS1F2CTRCDAOKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11814360-B2 Isocyanates, derivatives, and processes for producing the same NOVOMER, INC. (US) 2023-11-14 US disclosed
US-11814498-B2 Polylactone foams and methods of making the same NOVOMER, INC. (US) 2023-11-14 US disclosed
US-11814498-B2 Polylactone foams and methods of making the same NOVOMER, INC. (US) 2023-11-14 US disclosed
US-20210324168-A1 POLYLACTONE FOAMS AND METHODS OF MAKING THE SAME NOVOMER, INC. 2021-10-21 US disclosed
US-20210277028-A1 METAL-ORGANIC FRAMEWORK CATALYSTS, AND USES THEREOF NOVOMER, INC. 2021-09-09 US disclosed
US-10961209-B2 Processes for producing beta-lactone and beta-lactone derivatives with heterogenous catalysts NOVOMER, INC. (US) 2021-03-30 US disclosed
US-10590099-B1 Processes for producing beta-lactone with heterogenous catalysts NOVOMER, INC. (US) 2020-03-17 US disclosed
US-10457624-B2 Systems and processes for thermolysis of polylactones to produce organic acids NOVOMER, INC. (US) 2019-10-29 US disclosed
US-20190076835-A1 PROCESSSES USING MULTIFUNCTIONAL CATALYSTS NOVOMER, INC. 2019-03-14 US disclosed
US-20190047972-A1 PROCESSES FOR PRODUCING BETA-LACTONE AND BETA-LACTONE DERIVATIVES WITH HETEROGENOUS CATALYSTS NOVOMER, INC. (US) 2019-02-14 US disclosed
US-20190002293-A1 Biobased Carbon Fibers and Carbon Black and Methods of Making the Same NOVOMER, INC. (US) 2019-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10590099-B1 Processes for producing beta-lactone with heterogenous catalysts HBZ, AGL, RIOX2 PRSS1 4749/4885F2 131/4885CTRC 2710/4885
US-20190002293-A1 Biobased Carbon Fibers and Carbon Black and Methods of Making the Same AGL, CBR1, FASN PRSS1 4695/4885F2 1704/4885CTRC 1867/4885
US-11814360-B2 Isocyanates, derivatives, and processes for producing the same IDH1, IDH2, IDH3A PRSS1 4528/4885F2 305/4885CTRC 4747/4885
US-10457624-B2 Systems and processes for thermolysis of polylactones to produce organic acids AGL, OSTC, POR PRSS1 2968/4885F2 167/4885CTRC 1001/4885
US-20210277028-A1 METAL-ORGANIC FRAMEWORK CATALYSTS, AND USES THEREOF PPOX, PCCA, MCCC2 PRSS1 3175/4885F2 29/4885CTRC 2317/4885
US-10961209-B2 Processes for producing beta-lactone and beta-lactone derivatives with heterogenous catalysts AGL, HBZ, RIOX2 PRSS1 4776/4885F2 150/4885CTRC 2893/4885
US-20190047972-A1 PROCESSES FOR PRODUCING BETA-LACTONE AND BETA-LACTONE DERIVATIVES WITH HETEROGENOUS CATALYSTS AGL, HBZ, RIOX2 PRSS1 4776/4885F2 150/4885CTRC 2893/4885
US-20190076835-A1 PROCESSSES USING MULTIFUNCTIONAL CATALYSTS COASY, PTGIS, POR PRSS1 2734/4885F2 27/4885CTRC 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.